156 related articles for article (PubMed ID: 32291726)
21. Willingness to Pay for a Quality-Adjusted Life Year among Gastrointestinal Cancer Patients at a Tertiary Hospital of Vietnam, 2022.
Tran BT; Tran TT; La NQ; Nguyen TTP; Nguyen MH; Huynh TMC; Vu HP
Asian Pac J Cancer Prev; 2024 May; 25(5):1725-1735. PubMed ID: 38809645
[TBL] [Abstract][Full Text] [Related]
22. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
Kouakou CRC; He J; Poder TG
Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
[TBL] [Abstract][Full Text] [Related]
23. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.
Martín-Fernández J; Polentinos-Castro E; del Cura-González MI; Ariza-Cardiel G; Abraira V; Gil-LaCruz AI; García-Pérez S
BMC Health Serv Res; 2014 Jul; 14():287. PubMed ID: 24989615
[TBL] [Abstract][Full Text] [Related]
24. Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.
Kouakou CRC; Poder TG
Eur J Health Econ; 2022 Mar; 23(2):277-299. PubMed ID: 34417905
[TBL] [Abstract][Full Text] [Related]
25. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
26. Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia.
Iskedjian M; De Vol E; Elshenawy M; Bazarbashi S
JCO Glob Oncol; 2020 Oct; 6():1609-1616. PubMed ID: 33108230
[TBL] [Abstract][Full Text] [Related]
27. Willingness to pay for a QALY: theoretical and methodological issues.
Gyrd-Hansen D
Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
[TBL] [Abstract][Full Text] [Related]
28. Willingness to pay for QALY: perspectives and contexts in Japan.
Igarashi A; Goto R; Yoneyama-Hirozane M
J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
[No Abstract] [Full Text] [Related]
29. WTP for a QALY and health states: More money for severer health states?
Shiroiwa T; Igarashi A; Fukuda T; Ikeda S
Cost Eff Resour Alloc; 2013; 11():22. PubMed ID: 24128004
[TBL] [Abstract][Full Text] [Related]
30. Health-Related Quality of Life and Willingness to Pay per Quality-Adjusted Life-Year Threshold-A Study in Patients with Epilepsy in China.
Gao L; Xia L; Pan SQ; Xiong T; Li SC
Value Health Reg Issues; 2015 May; 6():89-97. PubMed ID: 29698200
[TBL] [Abstract][Full Text] [Related]
31. Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.
Baker R; Bateman I; Donaldson C; Jones-Lee M; Lancsar E; Loomes G; Mason H; Odejar M; Pinto Prades JL; Robinson A; Ryan M; Shackley P; Smith R; Sugden R; Wildman J;
Health Technol Assess; 2010 May; 14(27):1-162. PubMed ID: 20525460
[TBL] [Abstract][Full Text] [Related]
32. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
33. Investigating the Willingness to Pay for a Contributory National Health Insurance Scheme in Saudi Arabia: A Cross-sectional Stated Preference Approach.
Al-Hanawi MK; Vaidya K; Alsharqi O; Onwujekwe O
Appl Health Econ Health Policy; 2018 Apr; 16(2):259-271. PubMed ID: 29307076
[TBL] [Abstract][Full Text] [Related]
34. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
Byrne MM; O'malley K; Suarez-Almazor ME
Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
[TBL] [Abstract][Full Text] [Related]
35. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis.
Aviles-Blanco MV
Health Econ Rev; 2021 Jul; 11(1):27. PubMed ID: 34297212
[TBL] [Abstract][Full Text] [Related]
37. Comparing WTP values of different types of QALY gain elicited from the general public.
Pennington M; Baker R; Brouwer W; Mason H; Hansen DG; Robinson A; Donaldson C;
Health Econ; 2015 Mar; 24(3):280-93. PubMed ID: 25625510
[TBL] [Abstract][Full Text] [Related]
38. Determinants of Willingness to pay for Employment-Based Health Insurance Among Governmental School Workers in Saudi Arabia.
Alharbi NS
Inquiry; 2021; 58():469580211060790. PubMed ID: 34798799
[TBL] [Abstract][Full Text] [Related]
39. Comparing the monetary value of a quality-adjusted life year from the payment card and the open-ended format.
Ye Z; Liu F; Ma J; Zhou Z; Wang C; Sun L
Cost Eff Resour Alloc; 2021 Jul; 19(1):45. PubMed ID: 34281574
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia.
Alsaqa'aby MF; Vaidya V; Khreis N; Khairallah TA; Al-Jedai AH
Ann Saudi Med; 2017; 37(6):433-443. PubMed ID: 29229891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
